Novo Nordisk

$69.46
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.66 (-0.94%) Today

$0.00 (0.00%) As of 8:01 PM UTC after-hours

Why Robinhood?

You can buy or sell Novo Nordisk and other stocks, options, and ETFs commission-free!

About NVO

Novo-Nordisk A/S, also called Novo Nordisk, is a healthcare company, which engages in the research, development, manufacture, and marketing of pharmaceutical products. It operates through the following segments: Diabetes & Obesity Care, and Biopharmaceuticals.

CEO

Lars Fruergaard Jørgensen

Employees

45,323

Headquarters

Bagsværd, Capital Region

Founded

1925

Market Cap

161.17B

Price-Earnings Ratio

25.40

Dividend Yield

1.47

Average Volume

839.94K

High Today

$69.73

Low Today

$69.30

Open Price

$69.52

Volume

573.66K

52 Week High

$75.86

52 Week Low

$58.36

Analyst Ratings

52%

of 31 ratings

Buy

52%

Hold

32%

Sell

16%

NVO Earnings

$0.00

$0.25

$0.51

$0.76

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Estimated

— per share

Actual

Available May 5, Pre-Market